under which circumstance does the fda allow verbal consent prior to participation in a research study?

FDA Verbal Consent Guidelines
The FDA allows verbal consent prior to participation in a research study under specific, limited circumstances tied to minimal risk and regulatory waivers. This approach prioritizes participant protection while enabling practical research scenarios.

Key Circumstances for Verbal Consent

Verbal consent is permitted when written consent is waived or altered under FDA regulations (21 CFR 56.109(c) or 21 CFR 50.24 for emergency research). Core conditions include:

• The study involves no more than minimal risk to subjects.

• The waiver does not adversely affect subjects' rights or welfare.

• Research cannot practicably proceed without the waiver.

• Additional pertinent information is provided after participation if appropriate.

For FDA-regulated studies, only the second condition strictly applies without further qualifiers, distinguishing it from broader HHS rules.

Practical Examples

• Minimal-risk surveys or interviews : Verbal scripts cover purpose, risks, benefits, and alternatives; no signature needed if literacy/cultural barriers exist.

• Cultural or community norms : Signing forms isn't standard, so verbal methods with witnesses ensure understanding—common in global or low-literacy groups.

• Short-form process : A witness (independent, fluent in the spoken language) attests to the oral presentation.

Blockquote from NYU Guidance :

"1. the research involves no more than minimal risk to the subjects;
2. the waiver or alteration will not adversely affect the rights and welfare of the subjects;
3. the research could not practicably be carried out without the waiver..."

Multiple Viewpoints

• IRB Perspective : Institutions like UCSF or NYU require a pre-approved verbal script covering all consent elements (risks, benefits, voluntariness).

• Researcher Angle : Useful for phone surveys or emergency minimal-risk trials, but must include open-ended questions like "What risks do you understand?" to confirm comprehension.

• Critics' Concern : Verbal consent risks misunderstandings without documentation, so REBs demand witness signatures or recordings.

Scenario| Written Consent Standard?| Verbal Allowed?| FDA Criteria Met?
---|---|---|---
Minimal-risk survey| No, if impracticable| Yes| Minimal risk + practicability 15
Cultural non-signing groups| Waiver possible| Yes, with alternative docs| Cultural norm exception 5
Emergency research| Short form OK| Yes (21 CFR 50.24)| Life-threatening, no alternatives 5
High-risk drug trial| Always required| No| Exceeds minimal risk 7

Recent Context (2026 Trends)

As of early 2026, forums discuss rising verbal consent use in post-pandemic digital studies (e.g., telehealth minimal-risk trials). No major FDA updates since 2023 guidance, but IRBs emphasize tech aids like audio recordings for verification. Speculation: With AI ethics scrutiny, expect tighter script reviews by 2027.

TL;DR : FDA permits verbal consent mainly for minimal-risk studies where written forms are impracticable, per 21 CFR waivers—always with IRB- approved scripts and safeguards.

Information gathered from public forums or data available on the internet and portrayed here.